Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesMEX:A 96 EV-to-OCF is 28.07 as of Aug. 13, 2026, which is 15% above its 10-year median of 24.49. GuruFocus rates MEX:A with a GF Score™ of 96/100 and a GF Value™ of MXN2,308.34. The stock has 4 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 84.51% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Agilent Technologies's Enterprise Value is MXN741,410 Mil.
Agilent Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 was MXN26,414 Mil. Therefore, Agilent Technologies's EV-to-OCF for today is 28.07.
The historical rank and industry rank for Agilent Technologies's EV-to-OCF or its related term are showing as below:
MEX:A'
s EV-to-OCF Range Over the Past 10 Years
Min: 17.33 Med: 24.49 Max: 44.04
Current: 30.14
During the past 13 years, the highest EV-to-OCF of Agilent Technologies was 44.04. The lowest was 17.33. And the median was 24.49.
MEX:A's EV-to-OCF is ranked worse than 84.51% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 6.35
vs MEX:A: 30.14
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Agilent Technologies's PE Ratio (TTM) for today is calculated as:
Agilent Technologies's share price for today is MXN2350.00.
Agilent Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN90.068.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Agilent Technologies EV-to-OCF Related Terms
Agilent Technologies EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Agilent Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's EV-to-OCF falls into.
Agilent Technologies's current Enterprise Value is MXN741,410 Mil.
Agilent Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN26,414 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies (MEX:A) has a EV-to-OCF of 28.07 as of Aug. 13, 2026. This is 15% above median its historical median of 24.49. Over the past decade, Agilent Technologies' EV-to-OCF has ranged from 17.33 to 44.04. According to the industry distribution chart, Agilent Technologies ranks #180 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 84.5%.
Is Agilent Technologies' EV-to-OCF too high?
Agilent Technologies' current EV-to-OCF of 28.07 is 15% above median its 10-year median of 24.49. Over the past 10 years, this metric has ranged from a low of 17.33 to a high of 44.04. The Medical Diagnostics & Research industry median EV-to-OCF is 6.35. Agilent Technologies' value of 28.07 is 342% above this industry median. Based on the distribution chart, Agilent Technologies ranks #180 out of 213 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Agilent Technologies has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' EV-to-OCF compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #180 out of 213 companies for EV-to-OCF. This places Agilent Technologies in the lower half of its industry. The industry median EV-to-OCF is 6.35. Agilent Technologies' value of 28.07 is 342% above this benchmark. Historically, Agilent Technologies' own EV-to-OCF has ranged from 17.33 to 44.04 over the past decade. While the company's 10-year median is 24.49 vs. the industry median of 6.35, Agilent Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 6.35, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current EV-to-OCF of 28.07 is 342% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 6.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current EV-to-OCF is 28.07, which is 15% above median its own 10-year median of 24.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Agilent Technologies (MEX:A) has a current EV-to-OCF of 28.07. The stock's GF Value™ is MXN2,308.34, compared to a current price of MXN2,350.00 — trading 1.8% above its estimated fair value. The current EV-to-OCF is 28.07, which is 15% above median its 10-year median of 24.49 and 342% above the Medical Diagnostics & Research industry median of 6.35. Agilent Technologies' overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Agilent Technologies (MEX:A), the current EV-to-OCF is 28.07 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (MEX:A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be overvalued.
The current stock price of MXN2,350.00 is trading 1.8% above its estimated GF Value™ of MXN2,308.34.
Key valuation signals for MEX:A:
EV-to-OCF: 28.07 (15% above median its 10-year median of 24.49)
GF Value™: MXN2,308.34 vs. price of MXN2,350.00 (1.8% above fair value)
Industry Position: 342% above the Medical Diagnostics & Research median (#180 of 213)
No single metric tells the full story. See the MEX:A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
96GF Score
Get the complete analysis for MEX:A
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:A has been successfully added to your 
